SENSEX NIFTY

Glaxosmithkline Pharmaceuticals Ltd

May 27, 2016 at 15:26 | Source: Moneycontrol.com
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, have recommended a Final Dividend of Rs. 3.50 (35 percent) on the face value of Rs. 10 each for Nine months/Financial Year ended March 31, 2016.
May 27, 2016 at 15:02 | Source: Moneycontrol.com
Dr. Lal Path Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, have recommended a dividend of Rs. 2.45 per equity share (at 24.5 percent on a face value of Rs. 10/- per share) for the year ended March 31, 2016.
May 27, 2016 at 13:20 | Source: Moneycontrol.com
Indoco Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, have recommended dividend of Rs. 0.20 per share on face value of Rs. 2/- per share (10 percent) for the year 2015-16, which will be paid on or after August 03, 2016 subject to approval by the shareholders at the 69th AGM.
May 27, 2016 at 13:19 | Source: Moneycontrol.com
Makers Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2016, inter alia, has recommended a dividend of Re. 1/- per share (10 percent) for the financial year ended March 31, 2016.
May 26, 2016 at 21:54 | Source: PTI
Daiichi Sankyo, Daiichi Sankyo (Thailand) Ltd, Sun Pharmaceutical Industries Ltd, Ranbaxy (Netherlands) BV and Ranbaxy (Thailand) Company Ltd entered into a termination agreement on May 26, 2016.
May 26, 2016 at 21:49 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals in its meeting held on May 25, 2016, re-appointed Mr. Raju Krishnaswamy as whole- time Director of the Company for period of 3 years with effect from August 01, 2016.
May 26, 2016 at 11:58 | Source: Moneycontrol.com
Bal Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2016, inter alia, has recommended a dividend of Re. 1/- per equity share of Rs. 10/- each i.e. 10 percent on the paid up equity share capital of the Company, for the financial year ended March 31, 2016.
May 26, 2016 at 09:10 | Source: PTI
The company had posted a net profit of Rs 102.85 crore for the same period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a filing to BSE.
May 25, 2016 at 15:15 | Source: Moneycontrol.com
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2016, has recommended a dividend of 500% on the Equity Share capital i.e. Rs. 50/- per equity share for the year ended March 31, 2016.
May 25, 2016 at 10:50 | Source: Moneycontrol.com
Brooks Laboratories Ltd has informed BSE that a Meeting of Board of Directors of the Company is scheduled to be held on May 27, 2016, inter alia, to consider and approve Audited Financial results of the Company, for the quarter/year ended March 31, 2016.
Messages on Glaxosmithkline Pharmaceuticals Ltd »

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

12.06 PM May 16th 2014

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

12.18 PM Apr 17th 2014

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

3.55 PM Mar 26th 2014

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

2.00 PM Mar 25th 2014

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

4.39 PM Mar 13th 2014

vk1939

Platinum Member

213 Followers

GlaxoSmithKline  

7.08 PM Feb 18th 2014

yrfriend007

Platinum Member

189 Followers

GlaxoSmithKline  

3.51 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

2.00 PM Feb 18th 2014

BSE/NSE Announcer

Platinum Member

13648 Followers

GlaxoSmithKline  

1.51 PM Feb 18th 2014

kabiroberoi
90

New Member

0 Follower

GlaxoSmithKline  

1.04 PM Feb 18th 2014

News across the web »
Feb 18, 2014 at 10:41 | Source: Economic Times
Feb 18, 2014 at 08:26 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.